British drug maker AstraZeneca's planned move to Cambridge will test the pharmaceutical industry's belief that its future lies in closer cooperation with academia.
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303643304579107200819988472.html?mod=pls_whats_news_us_business_f
via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702303643304579107200819988472.html?mod=pls_whats_news_us_business_f
Nessun commento:
Posta un commento